Triple-positive breast cancer (TPBC), i.e. HER2-positive (HER2+) and hormone receptors-positive breast cancer, is a specific subgroup of breast cancers. TPBC biology is characterized by strong mutual interactions between signaling pathways stimulated by estrogens and HER2 amplification. The present study aims to carry out a population-based analysis of treatment outcomes in a cohort of hormone receptor (HR) positive and negative breast cancer patients who were treated with anti-HER2 therapy in the Czech Republic. The BREAST research database was used as the data source for this retrospective analysis. The database covers approximately 95% of breast cancer patients treated with targeted therapies in the Czech Republic. The analysis included 6,122 HER2-positive patients. The patients were divided into two groups, based on estrogen receptor (ER) or progesterone receptor (PR) positivity: hormone receptor negative (HR-) patients had both ER- and PR-negative tumors (n=2,518), unlike positive (HR+) patients (n=3,604). HR+ patients were more often diagnosed premenopausal at the time of diagnosis, presented more often at stage I or II and their tumors were less commonly poorly differentiated. The overall survival (OS) was significantly higher in subgroups of HR+ patients according to treatment setting. When evaluated by stages, significantly higher OS was observed in HR+ patients diagnosed at stages II, III, and IV and regardless of tumor grade.
- MeSH
- lidé MeSH
- míra přežití MeSH
- nádorové biomarkery MeSH
- nádory prsu * farmakoterapie genetika MeSH
- prognóza MeSH
- receptor erbB-2 antagonisté a inhibitory genetika MeSH
- receptory pro estrogeny genetika MeSH
- receptory progesteronu genetika MeSH
- retrospektivní studie MeSH
- Check Tag
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Česká republika MeSH
- MeSH
- indukce remise metody MeSH
- kombinovaná terapie klasifikace metody MeSH
- lidé MeSH
- metastázy nádorů terapie MeSH
- nádory ledvin terapie MeSH
- prognóza MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- kazuistiky MeSH
Práce podává přehled o základní klasifikaci kryoglobulinémie, jejích klinických a laboratorních projevech. Jsou zmiňovány převážně aspekty postižení ledvin kryoglobulinemickou glomerulonefritidou. V kazuistikách jsou demonstrovány průběhy a terapie esenciálních a sekundárních kryoglobulinémií.
The authors present a review of the basic classification of cryoglobulinaemia, its clinical and laboratory manifestations. They mention in particular aspects of renal affections caused by cryoglobulinaemic glomerulonephritis. In case-histories they demonstrate the course and treatment of essential and secondary cryoglobulinaemias.
- MeSH
- dospělí MeSH
- hepatitida komplikace MeSH
- histologie MeSH
- kryoglobulinemie klasifikace komplikace patologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- nádory komplikace MeSH
- nemoci ledvin etiologie patologie terapie MeSH
- revmatické nemoci komplikace MeSH
- senioři MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- kazuistiky MeSH
- MeSH
- amyloidóza komplikace MeSH
- lidé MeSH
- plicní nemoci komplikace MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- kazuistiky MeSH
- MeSH
- Hodgkinova nemoc mortalita terapie MeSH
- lidé MeSH
- rizikové faktory MeSH
- Check Tag
- lidé MeSH
